Tuesday, June 6, 2023
6:00PM – 7:00PM ET
Please note this TeleECHO program is 6:00PM Eastern, 5:00PM Central, 4:00PM Mountain and 3:00PM Pacific.
David Xu, MD
Wills Eye Hospital
Thomas Jefferson University Hospitals
This virtually live TeleECHO educational series focuses on timely screening and identification of diabetic retinopathy (DR) and/or diabetic macular edema (DME) and the impact that treatment timing can have on vision. Engage with expert discussion to learn more about the benefits of early detection and intervention, treatment strategies, and ways to leverage technology/teleophthalmology to overcome screening barriers, enhancing healthy vision in diabetes.
This activity is designed to meet the educational needs of primary care providers, ophthalmologists, and other healthcare providers who manage patients who have or are at risk for DR/DME.
After completing the CME activity, learners should be better able to:
- Implement evidence-based recommendations for diabetic retinopathy (DR) screening and monitoring
- Examine the importance of early identification and timely treatment of DR and/or DME
- Discuss treatments and dosing strategies for the individualized treatment of patients with DR and/or DME
- Describe racial, ethnic and sex variations in the prevalence and disease course of DR
- Cultivate a team-based approach in caring for the DR patient
ACCREDITATION STATEMENT: Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT: Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 creditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]